Serum Hs-CRP in Periodontitis Patients With or Without Diabetes
- Conditions
- Periodontal DiseaseDiabetes Mellitus, Type 2
- Interventions
- Procedure: Scaling and root planing
- Registration Number
- NCT03908606
- Lead Sponsor
- Cairo University
- Brief Summary
the aim of this study was to assess serum levels of high sensitivity c reactive protein in periodontitis patients with and without type 2 diabetes in a trial to analyze its prognostic effect following non-surgical periodontal therapy.
- Detailed Description
Periodontitis and diabetes are chronic disorders with a two-way correlation as they can both stimulate an inflammatory response with subsequent formation of inflammatory mediators and cytokines. C reactive protein is an inflammatory plasma marker having a role in the systemic reaction to inflammation. thus, our aim in the current study was to evaluate serum levels of high sensitivity c reactive protein in periodontitis patients with and without type 2 diabetes in a trial to analyze its prognostic effect following non-surgical periodontal therapy. A total of 60 patients were enrolled in this study. ELISA was used for determination of hs- CRP. Non- surgical periodontal therapy was carried out for all periodontitis patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Diabetic patients type 2
- Periodontitis patients
- Smokers
- Pregnant females
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Periodontitis patients with diabetes type 2 Scaling and root planing scaling and root planing was administered to all patients. Serum samples were collected before and after treatment to assess hs-CRP levels. Glycated hemoglobin was measured before and after treatment Periodontitis patients Scaling and root planing scaling and root planing will be done to periodontitis patients. Serum samples were collected before and after treatment to assess hs-CRP levels.
- Primary Outcome Measures
Name Time Method clinical attachment level 3 months gain in clinical attachment level
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Cairo University
🇪🇬Cairo, Egypt